Showing results (251-260 of 285) with videos related to
Sort By:
Pageof 29
Hepatology (Baltimore, Md.)|August 12, 2020
Analysis of Hepatitis B Virus Haplotype Diversity Detects Striking Sequence Conservation Across Genotypes and Chronic Disease PhaseJosef Wagner, Lilly Yuen, Margaret Littlejohn, et al.Digestive Diseases and Sciences|August 24, 2018
Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 AnalysisSang Hoon Ahn, Patrick Marcellin, Xiaoli Ma, et al.Hepatology (Baltimore, Md.)|April 8, 2015
Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysisK Rajender Reddy, Marc Bourlière, Mark Sulkowski, et al.The Lancet. Gastroenterology & Hepatology|April 14, 2017
Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trialMaria Buti, Edward Gane, Wai Kay Seto, et al.The Lancet. Gastroenterology & Hepatology|April 14, 2017
Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-label trialMarc Bourlière, Pascaline Rabiega, Nathalie Ganne-Carrie, et al.The New England Journal of Medicine|December 5, 2008
Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis BPatrick Marcellin, E Jenny Heathcote, Maria Buti, et al.Gastroenterology|October 20, 2010
Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis BE Jenny Heathcote, Patrick Marcellin, Maria Buti, et al.Journal of Hepatology|December 24, 2013
Boceprevir for chronic HCV genotype 1 infection in patients with prior treatment failure to peginterferon/ribavirin, including prior null responseJohn M Vierling, Mitchell Davis, Steven Flamm, et al.The New England Journal of Medicine|April 15, 2014
Ledipasvir and sofosbuvir for untreated HCV genotype 1 infectionNezam Afdhal, Stefan Zeuzem, Paul Kwo, et al.The New England Journal of Medicine|June 24, 2011
Telaprevir for previously untreated chronic hepatitis C virus infectionIra M Jacobson, John G McHutchison, Geoffrey Dusheiko, et al.Pageof 29